Education
About Us
Working with TipRanks
Follow Us
Pharmagreen Biotech (PHBI)
:PHBI
PHBI Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume191.24K
Average Volume (3M)1.32M
Market Cap
$862.74K
Enterprise Value$838.78K
Total Cash (Recent Filing)$906.00
Total Debt (Recent Filing)$352.41K
Price to Earnings (P/E)―
Beta-0.16
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding663,645,750
10 Day Avg. Volume863,367
30 Day Avg. Volume1,318,260
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.97
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit483.17
Enterprise Value/Ebitda-119.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
PHBI FAQ
What was Pharmagreen Biotech ’s price range in the past 12 months?
Currently, no data Available
What is Pharmagreen Biotech ’s market cap?
Pharmagreen Biotech ’s market cap is $862.74K.
When is Pharmagreen Biotech ’s upcoming earnings report date?
Pharmagreen Biotech ’s upcoming earnings report date is Dec 19, 2025 which is in 228 days.
How were Pharmagreen Biotech ’s earnings last quarter?
Pharmagreen Biotech released its earnings results on Sep 02, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Pharmagreen Biotech overvalued?
According to Wall Street analysts Pharmagreen Biotech ’s price is currently Overvalued.
Does Pharmagreen Biotech pay dividends?
Pharmagreen Biotech does not currently pay dividends.
What is Pharmagreen Biotech ’s EPS estimate?
Pharmagreen Biotech ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmagreen Biotech have?
Pharmagreen Biotech has 663,645,750 shares outstanding.
What happened to Pharmagreen Biotech ’s price movement after its last earnings report?
Pharmagreen Biotech reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharmagreen Biotech ?
Currently, no hedge funds are holding shares in PHBI
---
Company Description
Pharmagreen Biotech
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
---
---